Evidence map›Paper›PMID 38055196›Full record

ArticleAmerican journal of respiratory and critical care medicine2024

Small Airway Disease in Pre-Chronic Obstructive Pulmonary Disease with Emphysema: A Cross-Sectional Study.

Stijn E Verleden, Jeroen M H Hendriks, Annemiek Snoeckx, Cindy Mai, Yves Mentens, Wim Callebaut, Bruno De Belie, Paul E Van Schil, Veronique Verplancke, Annelies Janssens and 9 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06905483 (Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients), which is not on this map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06905483 phase4completednot on this mapstarted 2025, after this paper: background citation

Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study

TypeinterventionalSponsorThammasat UniversityRan2025 to 2026Enrolled22ConditionsCOPD, Chronic Obstructive Pulmonary Disease (COPD), Small Airway Disease, Triple TherapyArmsBudesonide/Glycopyrronium/Formoterol (BGF), Fluticasone Furoate/Umeclidinium/Vilanterol (FUV)
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Preclinical models of COPD: a state of the art review.The European respiratory journal · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. From Web to Collapse: Small Airway Disease Trajectory in Chronic Obstructive Pulmonary Disease.American journal of respiratory and critical care medicine · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 5 countries.

Stijn E VerledenDivision of Thoracic Surgery, Antwerp Surgical Training, Anatomy and Research Centre.ORCID 0000-0002-9656-5844
Jeroen M H HendriksDivision of Thoracic Surgery, Antwerp Surgical Training, Anatomy and Research Centre.
Annemiek SnoeckxDepartment of Molecular Morphology Microscopy, Faculty of Medicine and Health Sciences.
Cindy MaiDepartment of Radiology.
Yves MentensDepartment of Pulmonology, General Hospital Herentals, Herentals, Belgium.
Wim CallebautDepartment of Pulmonology, General Hospital Voorkempen, Malle, Belgium.
Bruno De BelieDepartment of Pulmonology, General Hospital, Rumst, Belgium.
Paul E Van SchilDivision of Thoracic Surgery, Antwerp Surgical Training, Anatomy and Research Centre.
Veronique VerplanckeDepartment of Pulmonology.
Annelies JanssensDepartment of Thoracic Oncology, and.
Joseph JacobDepartment of Radiology, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.ORCID 0000-0002-8054-2293
Ashkan PakzadDepartment of Radiology, University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.
Thomas M ConlonComprehensive Pneumology Center, Institute of Lung Health and Immunity, Helmholtz Munich, Munich, Germany; and.
Guney GuvencComprehensive Pneumology Center, Institute of Lung Health and Immunity, Helmholtz Munich, Munich, Germany; and.
Ali Önder YildirimComprehensive Pneumology Center, Institute of Lung Health and Immunity, Helmholtz Munich, Munich, Germany; and.
Patrick PauwelsCenter for Oncologic Research, and.
Senada KoljenovicCenter for Oncologic Research, and.
Johanna M Kwakkel-Van ErpLaboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.
Thérèse S LapperreLaboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium.
Antwerp University Hospital · BEHelmholtz Zentrum München · DEUniversity of Antwerp · BENational Health Service · GBProvince of Antwerp · BEDirectorate-General Joint Research Centre · BEKemin (Belgium) · BEMallow General Hospital · IE

Funding

Bijzonder Onderzoeksfonds 46818Bijzonder Onderzoeksfonds 46822
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsthmaEmphysemaPulmonary Disease, Chronic ObstructivePulmonary EmphysemaCross-Sectional StudiesHumansLungX-Ray MicrotomographyCOPDemphysemasmall airways

Identifiers

PMID38055196
OpenAlexW4389376531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.